INTRODUCTION
Peptide sequences in which the C-terminal amide (-CONH-) or acid (-COOH) functional groups have been replaced by electrophilic moieties such as aldehyde (-CHO) [1, 2] , trifluoromethyl ketone (-COCF3) [3, 4] and a-oxo ester (-COCOOR) [5] [6] [7] , have yielded potent reversible inhibitors of the serine and cysteine proteinases. By choosing appropriate amino acids to occupy the P1 to P. positions of the inhibitor (nomenclature of Schecter and Berger [8] ), so as to fulfil the primary and subsite specificity requirements of individual members of these proteinase superfamilies, it has been possible to obtain reagents that exhibit pronounced selectivity of action.
As part of an ongoing programme aimed at the design of novel inhibitors for these two classes of proteinases (see, for example [9] [10] [11] ), we have developed a range of novel dipeptides of general formula Cbz-NHCH(R2)CONHCH(R')COCHO (Cbz, benzyloxycarbonyl; R1 and R2 represent the side-chain groupings of naturally occurring amino acids), in which the C-terminal amino acid has been chemically transformed into an electrophilic aamino glyoxal derivative -NHCH(R1)-COCHO. These putative inhibitors were synthesized from the corresponding peptidyldiazomethanes [Cbz-NHCH(R2)CONHCH(R1)COCHN2], by oxidative cleavage of the diazo group, using dimethyldioxirane (DMD) [12] .
The present paper reports on the kinetic analysis of the inhibition of typical members of the serine and cysteine proteinases by a series of these novel reagents.
EXPERIMENTAL Materials
N-Benzyloxycarbonyl-L-arginyl-L-arginyl-4-methylcoumarin-7-ylamide (Cbz-Arg-Arg-NHMec) was purchased from Bachem, Bubendorf, Switzerland. Bovine cathepsin B, bovine chymowhereas exhibits a K1 of 80 nm against cathepsin B. These values are some 10-fold and 3-fold lower than those reported for the corresponding peptide-aldehyde inhibitors of chymotrypsin and cathepsin B upon which the peptidyl-glyoxals were fashioned. Unexpectedly, the sequence Cbz-Pro-Ala-CHO, which was designed to inhibit elastase-like proteinases, exhibited no inhibitory activity towards porcine pancreatic elastase, even when used at concentrations as high as 200 ,csM.
were purchased from Sigma Chemical Co., Poole, Dorset, U.K. Human cathepsin B was extracted and purified from post-mortem liver, essentially as described by Barrett [13] . Samples of the purified proteinase, when subjected to SDS/ PAGE run under reducing conditions, gave a major band of Mr 26000 and a faint low-Mr (-3000) band.
Synthesis of peptide glyoxals
The following peptide glyoxals were prepared as putative inhibitors: chymotrypsin-targeted sequences, Cbz-Ala-Phe-CHO, Cbz-Val-Phe-CHO and Cbz-Pro-Phe-CHO; cathepsin Btargeted sequence Cbz-Phe-Ala-CHO-and elastase-targeted sequence Cbz-Pro-Ala-CHO. The details for the synthesis of the dipeptide glyoxals will be published elsewhere [12] . In essence, they were prepared, in almost quantitative yield, by the DMDcatalysed oxidative cleavage of the parent peptidyl-diazomethane in moist acetone and were obtained as their hydrates
[-COC(OH)2j, as confirmed by 1H-n.m.r. and elemental analysis.
Kinetic techniques
Inhibition studies on chymotrypsin Chymotrypsin (10 g1 of a -0.1 gzM stock solution in 1 mM HCI) was added to a solution (1 ml) of Succ-Ala-Ala-Pro-Phe-NHMec (50 uM) and inhibitor under study (0.1-100 #tsM) in 50 mM sodium phosphate buffer, pH 7.4, containing 100 mM NaCl, maintained at 37 'C. The rate of hydrolysis of substrate was monitored continuously by measuring the rate of increase in Abbreviations used: Cbz, benzyloxycarbonyl; Mec, 4-methylcoumarin-7-yl; MeO I To whom correspondence and request for reprints should be addressed. Inhibition studies with bovine and human cathepsin B A solution (10 ll) of cathepsin B (-50 nM) was added to a solution of (1 ml) of Cbz-Arg-Arg-NH-Mec (50 ,uM) and CbzPhe-Ala-CHO (10-300 nM) in 100 mM sodium phosphate buffer, pH 6.4, containing 2 mM cysteine, 1 mM EDTA and 0.1 % (w/v) Brij 35, maintained at 37 'C. The rate of substrate hydrolysis was monitored as described for chymotrypsin.
Determination of the operational molarity of the proteinase solutions Chymotrypsin was titrated with the spectrofluorimetric titrant 4-methylumbelliferyl p-guanidinobenzoate by the method of Jameson et al. [14] , whereas cathepsin B was titrated with accurate amounts of E-64 as described by Barrett [3] .
A number of points are noteworthy. First, in common with the peptide aldehydes, the glyoxal analogues are more potent inhibitors of the cysteine proteinases than they are of the serine proteinases. Thus the most potent inhibitor of chymotrypsin, Cbz-Pro-Phe-CHO, has a K1 of 0.8,M; this is to be compared with a K1 value of -82 nM obtained for the inhibition of bovine cathepsin B by Cbz-Phe-Ala-CHO. This latter sequence was also a potent inhibitor of the human proteinase (K1 -77 nM).
Secondly, a comparison of the K, values for the peptide aldehyde and their analogous glyoxal counterparts demonstrates that the latter are between 3-and 10-fold more potent inhibitors of their respective target proteinase than the former. We have endeavoured to carry out our inhibition studies under conditions as close as possible to those reported for the inhibition of the proteinases with the aldehyde inhibitors, and we are confident that the increase in potency obtained with our novel inhibitors is an accurate reflection of the relative potencies of the two classes of reagents.
Finally, the rank order of effectiveness observed within the chymotrypsin-specified sequences, Cbz-Pro-Phe-CHO > CbzVal-Phe-CHO > Cbz-Ala-Phe-CHO, is in keeping with the known subsite specificity requirements of the enzyme derived from previous substrate and inhibitor studies [3] . The inactivity of Cbz-Pro-Ala-CHO towards chymotrypsin (no inhibition observed using inhibitor concentrations up to 200 ,uM) is also in keeping with the known primary specificity of the proteinase.
The only unexpected finding to arise out of the present study was the complete lack of inhibitory activity of Cbz-Pro-Ala-CHO towards porcine pancreatic elastase. This is difficult to explain in light of the reportedly strong inhibition of this proteinase by the tripeptide aldehyde derivative acetyl-Ala-ProAla-H, for which a K, of -60 ,tM was obtained [1] . However, it does suggest that the glyoxal derivatives may be very useful in discriminating between members of the serine-proteinase subclass.
As yet, we have not examined the exact mechanism for the inhibition of the serine or cysteine proteinases with these novel reagents. However, it seems reasonable to suggest that they will probably form hemiketals and thiohemiketal adducts with the active-site serine and cysteine residues of the respective classes of proteinase, in a manner similar to that established for the peptide aldehydes [17] [18] [19] [20] . With the glyoxals, however, Ser'95 (chymotrypsin numbering) or Cys25 (papain numbering) could conceivably add to either the ketonic or aldehydic carbonyl groups of the inhibitor. On the basis of electrophilic character, one would favour addition to the latter, but the former may be better placed, geometrically speaking, to interact with the active-site nucleophiles of these proteinases. The use of inhibitors incorporating 13C labels at each of these positions, used in conjunction with n.m.r., could presumably distinguish between these two mechanisms.
In conclusion, we have developed a novel class of inhibitors for the serine and cysteine proteinases, and early indications suggest that their potency surpasses even that of peptide aldehydes, which have previously been demonstrated to be potent inhibitors of these two classes of proteinase. On the basis of results from previous studies using peptide aldehydes [21] , it seems reasonable to suggest that extension of the peptide glyoxal sequences so as to encompass the P3 and P4 subsites should result in the generation of inhibitors with improved potency.
Finally, we believe that further studies are warranted in order to examine more fully the mechanistic aspects of the inhibition and to extend the kinetic study to include the testing of peptide sequences targeted against the trypsin-like proteinases of the serine-proteinase subclass and the analogous clostripain-like cysteine proteinases.
